InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

- Current share price for SHL : $22.370

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11,056 Sonic to raise long term debt funding 13 Nov 2009 10:06AM $14.200 $22.370 risen by 57.54%
$11,056 New Auckland Laboratory Contract 13 Oct 2009 10:32AM $13.480 $22.370 risen by 65.95%
$11,056 Preliminary Final Report 2009 28 Aug 2009 9:02AM $13.880 $22.370 risen by 61.17%
$11,056 New Zealand Pathology and Sonic Earnings Update 18 Aug 2009 4:31PM $12.630 $22.370 risen by 77.12%
$11,056 US Acquisitions 12 Aug 2009 9:04AM $12.220 $22.370 risen by 83.06%
$11,056 Lademannbogen Acquisition July 2009 14 Jul 2009 9:44AM $11.490 $22.370 risen by 94.69%
$11,056 Australian Federal Budget 2009/10 13 May 2009 10:14AM $12.320 $22.370 risen by 81.57%
$11,056 Half Yearly Report and Accounts 24 Feb 2009 9:32AM $11.950 $22.370 risen by 87.20%
$11,056 Auckland Pathology Contract - Update 12 Feb 2009 9:41AM $13.350 $22.370 risen by 67.57%
$11,056 Completion of Debt Refinancing 8 Dec 2008 9:40AM $13.300 $22.370 risen by 68.20%
$11,056 2008 Annual General Meeting Managing Director Presentation 20 Nov 2008 9:40AM $12.950 $22.370 risen by 72.74%
$11,056 A$425 Million Equity Raising 13 Nov 2008 9:33AM $12.410 $22.370 risen by 80.26%
$11,056 Market Update and Capital Raising 12 Nov 2008 9:39AM n/a $22.370 n/a
$11,056 Trading Halt 12 Nov 2008 9:03AM n/a $22.370 n/a
$11,056 Auckland Pathology Contract 25 Sep 2008 12:45PM $13.300 $22.370 risen by 68.20%
$11,056 Preliminary Final Report 21 Aug 2008 9:32AM $14.000 $22.370 risen by 59.79%
$11,056 Sonic Healthcare establishes additional Debt Facility 31 Jul 2008 4:54PM $13.550 $22.370 risen by 65.09%
$11,056 NHS tender update 4 Jul 2008 10:02AM $14.010 $22.370 risen by 59.67%
$11,056 Swiss acquisition and settlement of Labor 28 acquisition 2 Jul 2008 9:11AM $14.770 $22.370 risen by 51.46%
$11,056 SHL TO ACQUIRE CLINICAL LABORATORIES OF HAWAII 30 Jun 2008 9:31AM $14.550 $22.370 risen by 53.75%
$11,056 SHL to acquire GLP Medical Group in Germany 16 Jun 2008 9:07AM $14.400 $22.370 risen by 55.35%
$11,056 SHL TO ACQUIRE THE LABOR 28 GROUP IN BERLIN GERMANY 2 Jun 2008 9:11AM $14.740 $22.370 risen by 51.76%
$11,056 SHL UK PATHOLOGY TENDER ANNOUNCEMENT 10 Apr 2008 9:27AM $14.830 $22.370 risen by 50.84%
$11,056 Half Year Accounts 26 Feb 2008 9:35AM $13.800 $22.370 risen by 62.10%
$11,056 Sonic Healthcare makes further U.S. Acquisitions 3 Jan 2008 9:12AM $16.750 $22.370 risen by 33.55%

776 - 800 of 833 results

Page 32 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.